Tosoh Bioscience LLC is hosting a series of educational seminars, featuring column selection guidance, tips and tricks to extend column lifetime, and a focus on the analysis of biomolecules and monoclonal antibodies.

Thursday, April 24, 2014
8:15 am - 4:00 PM


Courtyard Rockville Marriott
2500 Research Blvd
Rockville, MD 20850

There is no course fee for this one-day seminar. Lunch will be provided. Registration deadline is April 8. Check back as additional talks are added to the schedule.

Who Should Attend:
This course is designed to benefit a range of HPLC users, from beginners to more advanced chromatographers.

What Will Be Covered:

"Importance of Column Selection in HPLC” - Atis Chakrabarti, Ph.D., Manager, Technical Service, Tosoh Bioscience


With the basic knowledge of HPLC and theory, selection of the right column is the next most important thing. This is like solving a puzzle considering the many different selection criteria to consider; some of which are straight forward, some not but complicated and interdependent. This requires critical identification of stationary phase based on the characteristics of the sample, complexity of the mixture, the difference in chemistry among the components of the mixture and goal of the separation. Selecting a right column is a science but the artistic skills a chromatographer gains through hands-on experience is important too. With the advancement of technology more choices of columns and packing materials are available for selection which is obviously appropriate and useful for ever expanding range of individual needs. This presentation is intended to assist the attendees in column selection and method development with a focus on biomolecules.
"Separation of Biomolecules using Different Modes of Analytical Chromatography Columns" - Justin Steve, Technical Service Specialist, Tosoh Bioscience

Antibodies and recombinant proteins are now widely used for the therapeutic treatment. The evaluation of the heterogeneity of the therapeutic antibody is essential for the development, stability study and quality control of the final product. Protein heterogeneity is generated by posit-translational modifications, decomposition or chemical modification. These increase the risk of anaphylaxis or immunoreaction if not separated. In this presentation we have shown the use of high resolution nonporous resin columns for Ion Exchange Chromatography (IEX) and Hydrophobic Interaction Chromatography (HIC) to detect even 1 residue difference of the proteins. Size exclusion chromatography (SEC) is suitably used to separate the monomer (150 kDa) and the dimer (300kDa) of a human monoclonal antibody to very good baseline resolution. Papain and pepsin digested antibodies could be resolved to separate Fc, Fab and intact protein to the baseline resolution by size exclusion chromatography. Analysis of Aggregates, fragments and PEGylated proteins and the analysis of hapten conjugated protein using SEC are also reported in this presentation. This presentation is focused on the overview of the columns available for the detection and separation of protein heterogeneity by HPLC using four different modes of chromatography such as SEC, IEX, RPC and HIC.
“Separation of Monoclonal Antibody Monomer from High Molecular Weight (HMW), Low Molecular Weight (LMW) and Other Heterogenic Impurities using Different Modes of Chromatography” - Atis Chakrabarti, Ph.D.

Protein aggregation is a biological phenomenon. There are many reasons why the aggregates or the high molecular weight (HMW) species form. Mostly the mis-folded proteins have a tendency to form aggregate. Both intra- or extra-cellular protein aggregates are found. These protein aggregates are often toxic; protein aggregates have been implicated in a wide variety of disease known as amyloidosis, including Alzheimer’s, Parkinson’s and prion disease.

Nowadays, monoclonal antibody proteins are widely being used in the field of bio therapeutics. These bio therapeutic proteins must be free from aggregates. Separation of the pure antibody monomer needs to be very well resolved from its dimer and higher order aggregates. Similarly for quality control and regulatory purpose the separation of antibody fragments or low molecular weight (LMW) species is also very much essential.

The species other than the monomer might induce toxic side effects to the body if not removed. Even if the impurities are non-toxic, the mere presence of these species may reduce the potency of the final formulation and hence need to be removed.

Many chromatographic modes can be coupled to separate complex mixtures, variants or impurities otherwise inseparable by a single mode of chromatography. A very favorable combination is Size Exclusion Chromatography (SEC) and Reversed Phased Chromatography (RPC). SEC and RPC are some of the most frequently used chromatographic modes for analytical separations of biomolecules, particularly monoclonal antibodies. The separation mechanism is orthogonal and the mobile phases are compatible.

Analytical SEC columns particularly one packed with 30 nm wider pore size, 3 μm particles with larger molecular exclusion limit can be used to separate as well as quantitate the aggregates or HMW species as a function of their hydrodynamic volume. A well resolved symmetric and apparently pure protein peak obtained from size exclusion chromatography need to be checked by another mode for the presence of any variants. A reversed phase chromatography using analytical column with wide pore size of 30 nm for maximum mass transfer is expected to be useful for the separation of large biomolecules such as proteins as well as their hydrophobic variants.

Here we discuss the use of analytical columns from two different modes of chromatography (SEC and RPC) in separation of monomer of proteins and monoclonal antibodies from their HMW and LMW impurities and variants.

“Light Scattering for Absolute Macromolecular Characterization” - Stephanie Cope, Ph.D., Applications Scientist, Wyatt Technology

Light scattering (LS), including classical and dynamic, has been widely employed to characterize protein solutions and other biomolecules. Static light scattering, especially multi-angle light scattering (MALS), determines the absolute molar mass, size, and conformation of macromolecules in solution, facilitating the characterization of molecular heterogeneity and impurity profile. Dynamic light scattering (DLS), also known as quasi-elastic light scattering (QELS), directly measures the translational diffusion coefficient from which the hydrodynamic radius of a molecule is derived. The power of MALS/QELS combined with HPLC (such as SEC, RPC, IEC, etc.) will be discussed and demonstrated through various applications.
"Separation of Half-mAb and Half-mAb Equivalents with High Resolution Using Size Exclusion Chromatography Packed with a Unique Controlled Pore Technology" - Justin Steve

Monoclonal antibody research continues to grow in an effort to develop effective biotherapeutics for a wide range of diseases. Recent research has shown an interest into mAb half-bodies as therapeutic vectors as they can be further targeted for conjugation, enzyme labeling, or antibody immobilization. Monoclonal antibody half-bodies can be generated through genetic engineering of cells or by selective reduction of hinge-region disulfide bonds present in the monoclonal antibody by mild reducing agents such as 2-MEA, DTT or TCEP. TCEP (tris(2-carboxyethyl) phosphine) is a mild reducing agent commonly used in the reduction of hinge region disulfide bonds. Unlike 2-MEA or DTT, TCEP is odorless and more resistant to oxidation in the presence of air making it a more stable reducing agent and a commonly used reagent in mAb half-body formation. As expected, mAb half-bodies have a molecular weight of approximately 70 kDa, or one half of that of the intact monoclonal antibody. Bovine Transferrin, with a molecular weight of 78 kDa is expected to simulate the half-mAb species when chromatographically separated using SEC and can be used as a molecular weight marker. This presentation will show the use of new TSKgel SW mAb columns.

"Optimization of Conjugate Vaccine Chemistry using Design of Experiment and SEC Analysis" - Andrew Lees, Ph.D., Founder and Scientific Director, Fina Biosolutions LLC

Conjugate vaccines consist of a protein chemically linked to carbohydrate polymers. These vaccines are highly effective but are among the most expensive and complex of the routine pediatric vaccines. For example Pfizer’s Prevnar conjugate vaccine for S. pneumonia consists of 13 capsular polysaccharides each linked to a protein. As each polysaccharide has a unique structure, synthesis of each must be optimized. This presents a multivariant problem that is well suited to the use of Design of Experiment (DOE). Key to using DOE is the ability to efficiently and rapidly analyze the products. We use Tosoh TSKgel PWxl series size exclusion HPLC columns with refractive index and UV detection for analysis, coupled with multi-angle light scattering for analysis. Our approach is being adopted by several emerging market vaccine companies to help them develop affordable conjugate vaccines.

"Troubleshooting, Column Lifetime Tips and Tricks, Questions" - Atis Chakrabarti

HPLC system and analytical chromatography columns are costly. Method development is time consuming and costly too. It is important to employ an HPLC system that is optimized with regards to extra-column band broadening to take full advantage of the high column efficiency that can be obtained on analytical columns. This presentation is about common but often ignored method development and troubleshooting issues, discussion of column lifetime issues encountered in different modes of analytical chromatography in general. At the end of this presentation, the floor will be opened for open discussion among the attendee column chromatographers.

Space is limited, so reserve your seat today!

Question Title

Name

Question Title

Company

Question Title

Address 1

Question Title

Address 2

Question Title

City/Town

Question Title

State/Province

Question Title

Zip/Postal Code

Question Title

Country

Question Title

Email Address

Question Title

Phone Number

Question Title

What chromatographic mode do you work in?

Question Title

What HPLC columns do you currently use?

T